Recombinant Chicken Protein Asterix (WDR83OS)

How does Chicken Protein Asterix compare to mammalian orthologs?

The chicken Asterix protein (101 amino acids) is slightly shorter than its human counterpart (106 amino acids) . WDR83OS is highly conserved across species, with orthologs identified in humans, chimpanzees, mice, rats, bovine, canine, frog, zebrafish, and even invertebrates like Drosophila melanogaster and Caenorhabditis elegans . This conservation suggests that Asterix performs fundamental cellular functions that have been preserved throughout animal evolution.

Despite variations in length, the functional domains appear to be conserved, particularly given its consistent role in the PAT complex across species. The specific differences in functional properties between chicken and mammalian Asterix require further comparative biochemical analysis.

What methodologies are appropriate for studying Asterix in developmental contexts?

Based on research involving Asterix/WDR83OS, several approaches are effective:

• Animal models: Zebrafish models lacking Wdr83os function have successfully demonstrated its role in the nervous system, craniofacial development, and lipid absorption .

• Genetic analysis: Family-based rare variant analyses using exome sequencing (ES) has been effective for identifying biallelic variants and correlating them with phenotypes .

• Longitudinal studies: Tracking developmental parameters (such as head circumference) over time has revealed progressive changes associated with WDR83OS mutations .

• Biochemical profiling: Measuring bile acids, bilirubin, and liver enzymes has helped characterize the phenotypic effects of WDR83OS variants .

What expression systems are optimal for producing functional Recombinant Chicken Protein Asterix?

The most validated expression system for Recombinant Chicken Protein Asterix is E. coli with an N-terminal His tag . This system has successfully produced the full-length protein (amino acids 1-101) with purity greater than 90% as determined by SDS-PAGE .

The expression construct typically contains:

• Complete coding sequence (amino acids 1-101)

• N-terminal His tag for purification

• Appropriate bacterial promoter system

When designing expression constructs, researchers should consider:

• Codon optimization for E. coli

• Inclusion of protease cleavage sites if tag removal is desired

• Vector compatibility with high-density bacterial culture

For applications requiring post-translational modifications, alternative expression systems such as insect cells or mammalian cells might be worth exploring, though these haven't been documented in the available literature for chicken Asterix specifically.

What are the optimal reconstitution and storage conditions for Recombinant Chicken Protein Asterix?

For reconstitution:

• Briefly centrifuge the vial prior to opening to bring contents to the bottom

• Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to 5-50% final concentration (recommended: 50%)

• Aliquot for long-term storage

Storage conditions:

• Store lyophilized powder at -20°C/-80°C upon receipt

• Store reconstituted aliquots at -20°C/-80°C for long-term storage

• Working aliquots can be maintained at 4°C for up to one week

• Avoid repeated freeze-thaw cycles

The protein is typically supplied in Tris/PBS-based buffer with 6% Trehalose at pH 8.0 , suggesting these conditions are optimal for stability.

How can researchers validate the structure and function of recombinant Asterix protein?

While the search results don't provide specific assays for Chicken Protein Asterix, several approaches would be appropriate based on its known function:

• Structural validation:

  • SDS-PAGE to confirm molecular weight (~12 kDa plus tag size)

  • Western blotting using anti-His tag or specific anti-Asterix antibodies

  • Circular dichroism to assess secondary structure

• Functional validation:

  • Co-immunoprecipitation with CCDC47 (its partner in the PAT complex)

  • In vitro binding assays with known interaction partners

  • Complementation studies in cells with WDR83OS knockdown

• Activity assessment:

  • Protein folding assistance assays using model transmembrane proteins

  • Cell-based assays measuring membrane protein insertion efficiency

What human diseases are associated with WDR83OS mutations and how does this inform chicken Asterix research?

Homozygous variants in WDR83OS are associated with a neurodevelopmental syndrome characterized by:

• Neurodevelopmental disorder (14/14 affected individuals)

• Facial dysmorphism (13/14)

• Intractable itching (9/14)

• Elevated bile acids (5/6 tested)

Additional features include:

• Normal to mildly elevated liver enzymes

• Normal bilirubin levels

• Progressive reduction in relative head circumference in some cases

These findings highlight the importance of WDR83OS in:

• Neural development and function

• Craniofacial development

• Bile acid metabolism

Chicken Asterix research can provide valuable insights into these processes through comparative studies, especially given the conservation of this protein across species. Using chicken as a model system might be particularly valuable for studying developmental aspects of Asterix function.

How can zebrafish models contribute to understanding Asterix function in comparison to chicken models?

Zebrafish models lacking Wdr83os function have successfully demonstrated its role in:

• Nervous system development

• Craniofacial formation

• Lipid absorption

These phenotypes align with the human disease manifestations, confirming the evolutionary conservation of Asterix function.

For comparative studies, researchers should consider:

• Zebrafish models are advantageous for high-throughput screening and real-time visualization of developmental processes

• Chicken models offer closer evolutionary relationship to mammals and more complex developmental processes

• Combining findings from both models can provide complementary insights into Asterix function

What technical considerations are important when analyzing Asterix function in protein folding pathways?

When studying Asterix's role in protein folding:

• Substrate selection: Focus on large proteins with multiple transmembrane domains, as these are the primary clients of the PAT complex .

• Cellular context: Consider the endoplasmic reticulum environment where Asterix naturally functions.

• Complex formation: Always consider the interaction with CCDC47, as Asterix functions as part of the PAT complex rather than in isolation .

• Detection methods: Use techniques sensitive enough to capture the potentially transient interactions during protein folding.

• Specificity controls: Include experiments with known non-substrate proteins to demonstrate the specificity of Asterix's chaperone function.

• Stress conditions: Test function under various cellular stresses that might affect protein folding (e.g., heat shock, reducing agents).

How can structural studies of Chicken Protein Asterix inform drug development for WDR83OS-related disorders?

While current search results don't detail structural studies of Chicken Protein Asterix, such research could potentially:

• Identify critical binding interfaces between Asterix and CCDC47 that could be targeted with small molecules to modulate PAT complex function.

• Reveal substrate-binding regions that could be exploited to enhance or restore chaperone activity in disease variants.

• Provide templates for in silico screening of compounds that might stabilize mutant Asterix proteins.

• Help design peptide mimetics that could substitute for dysfunctional protein domains.

Notably, the human disease phenotypes associated with WDR83OS variants suggest that enhancing Asterix function could potentially address neurodevelopmental issues and bile acid metabolism abnormalities .

What are the limitations of current antibodies for Chicken Protein Asterix research?

• Cross-reactivity: Verify whether antibodies raised against human or mammalian Asterix effectively recognize the chicken ortholog, given the differences in amino acid sequence.

• Epitope accessibility: Determine if antibodies can detect Asterix in its native conformation within the PAT complex or only when denatured.

• Application range: Validate antibodies for specific applications (Western blotting, immunoprecipitation, immunofluorescence, etc.).

• Batch variability: Monitor consistency between antibody batches, especially for polyclonal antibodies.

• Background in chicken tissues: Test for non-specific binding in chicken-derived samples.

How do recent advances in genetic studies inform approaches to studying Asterix function in chickens?

Recent genetic studies revealing WDR83OS's role in human disease suggest several approaches for chicken research:

• CRISPR/Cas9 genome editing: Generate chicken cell lines or embryos with specific mutations mirroring those found in human patients.

• Conditional knockouts: Develop systems to study temporal and tissue-specific requirements for Asterix during development.

• Reporter systems: Create fusion proteins or reporters to track Asterix localization and dynamics in chicken cells.

• Transcriptomics: Compare gene expression changes between wild-type and Asterix-deficient chicken cells to identify downstream pathways.

• Interactome studies: Use proteomics approaches to identify chicken-specific interaction partners that might reveal species-specific functions.

These approaches could reveal both conserved and divergent aspects of Asterix function between chickens and mammals, potentially identifying new therapeutic targets for WDR83OS-related disorders.